公司資料
Lantern PharmaAI 股價、新聞與催化劑
- 股票代碼:
- LTRN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.71 USD (-11.40%)
收盤價
最後更新: 2026年9月17日
47.7M USD
市值
股價為何變動
截至 2026年9月17日，LTRN 下跌 11.4%，收於 $1.71。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Lantern Pharma is a technology-enabled oncology company focused on AI-assisted drug discovery and precision cancer medicine. Its platform combines computational tools with targeted oncology development.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Lantern sits at the intersection of AI and oncology biotechnology.
商業模式特徵
The company depends on platform adoption, clinical progress, and the translation of AI-driven discovery into pipeline value.
生技產業定位
Lantern is a hybrid AI-oncology name whose stock depends on both platform credibility and drug-development progress.
未來催化劑
- Lantern’s catalysts are its AI-driven oncology discovery platform and any partnered or internal pipeline update. The company needs evidence that the platform is producing more than just tools.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。